MediPaCe
Making Patient Engagement a Reality

A powerful shift is underway in the evolving landscape of life sciences. Patient centricity today has outgrown its buzzword status and is now a critical ethos reshaping the industry.

For decades, placing patients at the heart of healthcare decisions has been gaining momentum. Life science players— including large pharmaceutical companies, smaller biotech organisations and med-tech companies—agree that a renewed focus can unlock new opportunities for innovation, improve health outcomes and achieve lasting success in a dynamic and demanding industry.

MediPaCe excels in deploying scalable, repeatable change models underpinned by cutting-edge research. The company partners with clients, patients, families and healthcare professionals, ensuring a people-first approach that transforms company-level change measurement and deployment. Its unique methodology sets the standard for impactful, collaborative healthcare solutions.

“We are a values-first patient involvement and research company with the core belief that only by working in equal partnership with patients can we deliver the outcomes that matter the most,” says Dr. Jenny Royle, strategic lead of MediPaCe.

Focusing on patients’ needs, priorities and expectations when making critical decisions throughout the value chain— from clinical trial design to creating impactful patient support programs—is now essential for all clients. This is where MediPaCe plays a pivotal role.

The company provides four main services: developing and implementing patient-centric strategies and internal infrastructure, driving behavioural and organisational changes and navigating complex corporate ecosystems. It also delivers innovative patient involvement activities and conducts actionable, real-world, patient-centred research to support the creation of patient experience data (PED) packages required by authorities.

Lastly, MediPaCe offers a distinct patient identification tool using omnichannel tactics to locate and identify patients and families in hard-to-reach or underrepresented communities, including those with rare conditions.

Dr. Sandeep Bagga, research and operations lead at MediPaCe, says, “Our team has expertise in conducting complex mixed methods and multi-country studies that capture deep, nuanced insights into the lived experiences of patients and caregivers. Our findings have helped ensure healthcare solutions are valued and truly meet patient needs, driving better health outcomes, experience and satisfaction.”

MediPaCe delivers efficient, cost-effective clinical trial solutions, addressing the industry’s demand for tighter margins and compressed timelines. Recognising the persistent challenges of adherence and attrition in clinical trials, the company leverages its team of behavioural scientists to work directly with patients. Applying advanced behavioural models enhances patient engagement and retention, ensuring more reliable trial outcomes. MediPaCe’s innovative approach optimises trial efficiency and improves overall success rates for its clients.

We are a values-first patient involvement and research company with the core belief that only by working in equal partnership with patients can we deliver the outcomes that matter the most.

For example, MediPaCe designed a clinical trial to measure new and, as yet unlabelled, treatment benefits observed by the patient community. To achieve this, the company integrated insights from patients and healthcare professionals. It coordinated and hosted two advisory boards delivering actionable recommendations on trial design, eligibility criteria and measurement tools. This collaboration ensured meaningful endpoints and practical considerations, fostering strong and lasting partnerships that will continue to provide strategic advice on trial delivery and reporting.

Established as an opinion leader, MediPaCe has scripted many such success stories over the years. As an agile company, it rapidly embraces new technologies and deploys them to enable clients to remain competitive. The newly opened office in Finland extends MediPaCe’s global reach, facilitating innovative, multi-stakeholder and industry research collaborations. This expansion aims to advance clinical science and healthcare through strategic partnerships and coalition management across Europe by focusing on patient benefits.